FLOT1 and cancer: Our data have demonstrated that miR‐485‐5p might target the degradation of FLOT1 mRNA in CC, and the deficiency of miR‐485‐5p may contribute to the more aggressive malignant phenotype, which includes an increase in cancer cell proliferation, invasion and metastasis.